237 related articles for article (PubMed ID: 18334868)
1. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
2. Is acid relevant in the genesis of dyspeptic symptoms associated with nonerosive reflux disease?
Savarino V; Savarino E
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):252-4. PubMed ID: 18334866
[TBL] [Abstract][Full Text] [Related]
3. Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.
Battaglia E; Grassini M; Navino M; Niola P; Verna C; Mazzocchi A; Clerici C; Morelli A; Bassotti G
Dig Liver Dis; 2007 Dec; 39(12):1052-6. PubMed ID: 17913607
[TBL] [Abstract][Full Text] [Related]
4. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile.
Tack J; Caenepeel P; Arts J; Lee KJ; Sifrim D; Janssens J
Gut; 2005 Oct; 54(10):1370-6. PubMed ID: 15972301
[TBL] [Abstract][Full Text] [Related]
6. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
7. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
8. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
Chand N; Johnson DA; Tabangin M; Ware JC
Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
[TBL] [Abstract][Full Text] [Related]
9. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease.
Brillantino A; Monaco L; Schettino M; Torelli F; Izzo G; Cosenza A; Marano L; Di Martino N
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1136-43. PubMed ID: 18946360
[TBL] [Abstract][Full Text] [Related]
11. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
12. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
Madsen LG; Wallin L; Bytzer P
Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
[TBL] [Abstract][Full Text] [Related]
14. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
16. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
Tipnis NA; Rhee PL; Mittal RK
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G469-74. PubMed ID: 17556589
[TBL] [Abstract][Full Text] [Related]
17. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.
Armstrong D; Talley NJ; Lauritsen K; Moum B; Lind T; Tunturi-Hihnala H; Venables T; Green J; Bigard MA; Mössner J; Junghard O
Aliment Pharmacol Ther; 2004 Aug; 20(4):413-21. PubMed ID: 15298635
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
[TBL] [Abstract][Full Text] [Related]
19. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
[TBL] [Abstract][Full Text] [Related]
20. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
